| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
282.53(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,579,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$252,708,726 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
37 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Severino Michael |
Vice Chairman |
• – – |
2022-05-10 |
4 |
OE |
$58.88 |
$5,960,468 |
D/D |
100,000 |
252,103 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-09 |
4 |
S |
$149.53 |
$15,027,710 |
D/D |
(100,000) |
152,103 |
|
6% |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-09 |
4 |
OE |
$54.86 |
$5,621,478 |
D/D |
100,000 |
252,103 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-05-07 |
4 |
D |
$152.83 |
$35,762 |
D/D |
(234) |
43,539 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-06 |
4 |
S |
$150.10 |
$15,080,612 |
D/D |
(100,000) |
152,103 |
|
6% |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-06 |
4 |
OE |
$54.44 |
$5,454,790 |
D/D |
100,000 |
252,103 |
|
- |
|
| Hart Brett J |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
15,497 |
|
- |
|
| Tilton Glenn F |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
47,589 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
122,776 |
|
- |
|
| Austin Roxanne S |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
50,705 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
28,584 |
|
- |
|
| Burnside William H.l. |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
22,983 |
|
- |
|
| Waddell Frederick H |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
24,983 |
|
- |
|
| Roberts Rebecca B |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
9,753 |
|
- |
|
| Alpern Robert J |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
31,542 |
|
- |
|
| Meyer Melody B |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
12,523 |
|
- |
|
| Stewart Jeffrey Ryan |
EVP, Chief Commercial Officer |
• – – |
2022-03-24 |
4 |
S |
$159.20 |
$4,408,375 |
D/D |
(27,690) |
60,941 |
|
12% |
|
| Stewart Jeffrey Ryan |
EVP, Chief Commercial Officer |
• – – |
2022-03-24 |
4 |
OE |
$58.88 |
$1,630,387 |
D/D |
27,690 |
88,631 |
|
- |
|
| Durkin Brian L |
VP, Controller |
• – – |
2022-03-09 |
4 |
S |
$150.00 |
$2,794,301 |
D/D |
(18,628) |
19,094 |
|
-1% |
|
| Durkin Brian L |
VP, Controller |
• – – |
2022-03-09 |
4 |
OE |
$79.02 |
$923,112 |
D/D |
11,682 |
37,722 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-03-06 |
4 |
D |
$150.56 |
$53,449 |
D/D |
(355) |
43,773 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-03-05 |
4 |
D |
$150.56 |
$67,451 |
D/D |
(448) |
44,128 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-03-02 |
4 |
D |
$147.69 |
$119,629 |
D/D |
(810) |
44,576 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-03-01 |
4/A |
S |
$146.81 |
$3,682,189 |
I/I |
(25,000) |
53,500 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-03-01 |
4 |
S |
$146.81 |
$3,682,189 |
D/D |
(25,000) |
16,623 |
|
-4% |
|
641 Records found
|
|
Page 6 of 26 |
|
|
7.67 (4.58%) 
